Clinical Trial Update: Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the anti-diabetic effects of liraglutide in adolescents and young people with Type 1 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University at Buffalo | Conditions: Type 1 Diabetes | Phase 3 | Status: WITHDRAWN